drugset / Trial / NCT04559074
Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension
Phase 4
Completed
343 enrolled
Queen Mary University of London
Closed Loop Medicine Ltd · collabInnovate UK · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This trial is focusing on blood pressure control for patients with high blood pressure (hypertension) during the COVID-19 pandemic when seeing a doctor for advice may be difficult. The study utilises remote consultations by telephone or video conferencing. Patients record blood pressure and data into an electronic diary on their phone which is reviewed in consultations every 2 weeks by a clinician. Medication for this trial is amlodipine as an oral solution which is uptitrated accordingly for patients receiving medication (anticipated 200). 800 patients will be in an observational group recording the same readings and will not receive any medication.
Timeline
- Start
- 2020-10-23
- Primary completion
- 2021-11-10
- Completion
- 2021-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 1 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 2 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 3 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 4 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 6 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 7 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 8 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 9 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |